India’s efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents.
THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been (…)
Patent to plunder
By Amit Sengupta